CI
BIIB icon

Cowen Inc’s Biogen BIIB Stock Holding History

Cowen Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,000
Closed -$543K – 231
2017
Q2 		$543K Buy
+2,000
New +$529K 0.03% 210
2016
Q1 		– Sell
-1,485
Closed -$455K – 265
2015
Q4 		$455K Buy
+1,485
New +$427K 0.03% 197
2015
Q3 		– Sell
-3,585
Closed -$1.45M – 276
2015
Q2 		$1.45M Sell
3,585
-2,150
-37% -$863K 0.09% 138
2015
Q1 		$2.42M Buy
5,735
+4,735
+474% +$1.87M 0.2% 77
2014
Q4 		$339K Sell
1,000
-250
-20% -$80.9K 0.03% 170
2014
Q3 		$414K Buy
1,250
+150
+14% +$49.5K 0.04% 197
2014
Q2 		$347K Buy
+1,100
New +$331K 0.04% 192

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cowen Inc's BIIB Position: Q3 2017 in Review

Cowen Inc sold out of Biogen (BIIB) in Q3 2017, closing a stake of 2,000 shares — an estimated $543K sold.

Cowen Inc first reported a position in BIIB in Q2 2014 and held it in 7 quarters. The position peaked at $2.42M in Q1 2015. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Cowen Inc reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Cowen Inc sold 2,000 Biogen shares in Q3 2017, an estimated $543K.
  • Cowen Inc first reported a position in Biogen in Q2 2014 and held it in 7 quarters.
  • Cowen Inc's Biogen position peaked at $2.42M in Q1 2015.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.